Transmission of toxoplasmosis by renal transplant: a report of four cases.
Renoult
E
E
Service de Néphrologle, Laboratoire Central de Parasitologie et Mycologie, Centre Hospitaller et Régional de Nancy, France.
Biava
M F
MF
Hulin
C
C
Frimat
L
L
Hestin
D
D
Kessler
M
M
D000328:Adult; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000913:Antibodies, Protozoan / Q000097:blood; D002102:Cadaver; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D002955:Leucovorin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011739:Pyrimethamine / Q000627:therapeutic use; D012189:Retrospective Studies; D013411:Sulfadiazine / Q000627:therapeutic use; D014019:Tissue Donors; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000188:drug therapy / Q000635:transmission*
D000890:Anti-Infective Agents; D000913:Antibodies, Protozoan; D007166:Immunosuppressive Agents; D013411:Sulfadiazine; D002955:Leucovorin; D011739:Pyrimethamine